Author: admin

Former Air Force C-5 Galaxy Pilot Greg Born Releases “Built to Soar,” A Flight Manual for Businesses Navigating Chaos

“Greg Born, author of the new book “Built to Soar: Stop Flying Blind.” A former U.S. Air Force C-5 Galaxy pilot and seasoned business executive, Born translates battle-tested aviation principles into a practical flight manual for today’s business leaders.”
Greg Born, a former USAF C-5 Galaxy pilot turned business executive, announces the launch of his new book, “Built to Soar: Stop Flying Blind.” The book introduces a novel framework that applies the disciplined, battle-tested principles of high-stakes aviation to help leaders and entrepreneurs engineer their businesses for resilient growth and navigate today’s turbulent markets. It’s a practical guide to replacing operational chaos with clarity and control.

NASHVILLE, TN – 17 Jun, 2025 – In a business landscape rife with turbulence, countless leaders find themselves flying by the seat of their pants, wrestling with operational chaos, and burning through resources just to stay airborne. Addressing this pervasive problem, former U.S. Air Force C-5 Galaxy pilot and seasoned business executive Greg Born today announced the official launch of his highly anticipated book, “Built to Soar: Stop Flying Blind. Engineer Your Business For Unstoppable Business Growth.”

The book challenges the concept of the “accidental design” — the state of most businesses that have evolved through a series of reactive fixes, held together by what Born calls “sheer willpower and metaphorical duct tape.” This approach, he argues, leads to chronic inefficiency, team burnout, and missed opportunities. “Built to Soar” offers a radically different path: a disciplined framework for intentionally engineering a business with the same rigor and clarity used in high-stakes aviation.

“I spent years in both cockpits and conference rooms, and I kept seeing the same pattern,” says Born. “In aviation, we would never accept the level of ambiguity, process friction, and systemic flaws that are considered normal in many companies. Complacency can kill in an aircraft; it just kills a business more slowly. I wrote the book I wish someone had handed me 20 years ago—a practical, no-nonsense flight manual to move from accidental chaos to purposeful, engineered resilience.”

“Built to Soar” deconstructs the business into four core systems, using the powerful analogy of designing a high-performance aircraft:

  • The Mission: Defining a clear, actionable flight plan that replaces vague corporate platitudes.
  • The Airframe: Engineering a robust structure of processes and systems that can withstand stress.
  • The Crew: Implementing a disciplined system for getting the right people and behaviors on board.
  • The Flight Controls: Using the right data and leadership rhythms to navigate with confidence.

The book is filled with “Hangar Talk” insights, battle-tested checklists, and frameworks like the MAT model (Maintain, Analyze, Take Proper Action) for crisis management, a tool Born translated directly from his emergency procedure training as a pilot. It’s designed not for academics, but for leaders and entrepreneurs in the trenches who are tired of theory and ready for a blueprint that works.

“The goal isn’t just to survive the turbulence — it’s to build an organization that thrives in it,” Born adds. “It’s about freeing up leaders from constant firefighting so they can focus on strategy, growth, and leading their crew. It’s about building a business that doesn’t just stumble forward, but one that is truly built to soar.”

“Built to Soar: Stop Flying Blind.” is now available in paperback and e-book formats on Amazon and wherever books are sold.

About the Author:

Greg Born is a business executive, author, and a graduate of the U.S. Air Force Academy. As a former U.S. Air Force C-5 Galaxy pilot, his career took him from flying high-stakes global missions to holding executive roles in major corporations and startups. He leverages his unique background in aviation discipline and corporate leadership to help businesses replace operational chaos with clarity, purpose, and unstoppable growth. He is also the author of “Be A Better Leader: 1 Simple Thing.”

His author’s page is GregoryBorn.com

Media Contact
Company Name: Built To Soar Book
Contact Person: Greg Born
Email: Send Email
City: Nashville
State: TN
Country: United States
Website: https://www.gregoryborn.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Former Air Force C-5 Galaxy Pilot Greg Born Releases “Built to Soar,” A Flight Manual for Businesses Navigating Chaos

Bosch, DeWalt, and Hilti Fuel U.S. Power Tool Accessories Market Growth to $5 Billion by 2030 Through Strategic State-Level Initiatives – Arizton

“U.S. Power Tool Accessories Market Research by Arizton”
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2025–2030.

According to Arizton’s latest research report, the U.S. power tool accessories market is growing at a CAGR 7.16% of during 2024-2030.

 

Looking for More Information? Click: https://www.arizton.com/market-reports/us-power-tool-accessories-market

 

Report Scope:

Market Size (2030): USD 5 Billion

Market Size (2024): USD 3 Billion

CAGR (2024-2030): 7.16%

Historic Year: 2021-2023

Base Year: 2024

Forecast Year:2025-2030

Market Segmentation: Operations Type, Accessory Type, End Users, Industrial End Users, Distribution Channel, and Geography

Geographic Analysis: The U.S. (South, West, Midwest, and Northeast)

Largest Region: South

 

The U.S. power tool accessories market represents a dynamic and steadily expanding segment within the tools and hardware industry, propelled by rapid urbanization, evolving consumer lifestyles, and a growing culture of DIY and professional repair solutions. Increasingly time-constrained urban populations now prioritize on-demand, reliable, and efficient tools that align with their fast-paced personal and professional routines. Rising trends such as hybrid work models, increased teleworking, and higher female workforce participation have significantly altered consumption patterns, elevating demand for power tool accessories that support home maintenance, improvements, and light industrial projects during traditional work hours.

Furthermore, heightened health, safety, and sustainability awareness are reshaping consumer choices, with buyers seeking eco-friendly, durable, and precision-engineered accessories. Furthermore, technological advancements in product design and materials, coupled with innovations in distribution and digital engagement strategies, are redefining convenience and quality standards in the U.S. power tool accessories market. As urban infrastructure expands and expectations for quick, effective, and sustainable solutions rise, the market is positioned for sustained and robust growth in the coming years.

 

Key Drivers of the 2025 Market Surge

The Western U.S. continues to be a powerhouse of economic and infrastructure growth, directly impacting the demand for power tools and accessories. Several major construction projects are fueling this momentum:

  • California High-Speed Rail (CHSR): The ambitious USD 135 billion initiative connecting Los Angeles to San Francisco—with trains reaching up to 220 mph—is driving significant tool demand during early-phase construction.
  • WB1200, Seattle: This twin-skyscraper development, scheduled for completion in 2025, includes over 1,000 apartments and retail space, underscoring the boom in high-density urban projects.
  • Spring District, Bellevue: A USD 2.3 billion mixed-use project, contributing to Bellevue’s rapid growth, is enhancing demand for construction tools across residential and commercial segments.
  • Foothill Gold Line Extension, Los Angeles County: With Phase 2B1 slated for 2025 completion, this light rail expansion is not only boosting regional connectivity but also intensifying infrastructure-related tool usage.

 

Bosch, DeWalt, and Hilti Drive U.S. Power Tool Accessories Market Through State-Level Initiatives

Power tool brands are aggressively investing in state-specific initiatives to boost accessory adoption and user engagement. In California, Texas, and Florida, Bosch’s Power Tools Academy and Makita’s certification tracks are upskilling tradespeople and DIYers, directly influencing brand preference and repeat accessory purchases.

In Illinois, Ohio, and New York, Stanley Black & Decker and Bosch are scaling digital storefronts and interactive tutorials, which have led to measurable growth in online accessory sales, particularly in urban ZIP codes with dense contractor networks.

Manufacturers like Hilti and Husqvarna are introducing zero-interest financing and trade-in offers across Georgia, North Carolina, and Alabama, helping dealers and small contractors upgrade frequently while driving accessory consumption. Meanwhile, loyalty programs in metro areas like Los Angeles, Chicago, and New York, such as Husqvarna’s referral-based rewards, are boosting customer retention and word-of-mouth accessory sales, creating a feedback loop of usage and repurchase in competitive urban markets.

 

Offline Stores Continue to Lead U.S. Power Tool Accessories Market

Despite the rise of e-commerce, offline distribution continues to dominate the U.S. power tool accessories market. Established retail giants like Home Depot, Lowe’s, and Ace Hardware retain strong market share, supported by customers’ preference for in-person product evaluation, expert guidance, and instant product access.

Professional contractors and industrial users also rely heavily on authorized distributors and local dealers, valuing brand-certified products, tailored support, and technical assistance. These offline networks are further strengthened by in-store training sessions and promotional campaigns led by manufacturers, initiatives that drive deeper customer engagement and encourage frequent accessory upgrades. While online platforms expand, the trust, service, and immediacy offered by offline outlets remain central to the market’s structure.

 

Recent Market Activities

  • In March 2025, Milwaukee Tool expanded its SHOCKWAVE Impact Duty accessory line, launching next-gen drill and driver bits designed for enhanced durability and faster performance in demanding applications.
  • In October 2024, Stanley Black & Decker entered into an exclusive retail partnership with Lowe’s to launch a new series of CRAFTSMAN-branded power tool accessories.

 

Power Tool Accessory Market Thrives in Southern U.S. with Project-Driven Growth

The Southern U.S. continues to lead the power tool accessories market, propelled by large-scale infrastructure expansion, booming construction, and the rise of industrial hubs. States like Texas, Florida, and Georgia are at the forefront of commercial and residential development, significantly driving demand for heavy-duty cutting, drilling, and fastening accessories. This regional momentum is further supported by robust dealer networks and manufacturer-led financial programs, including leasing, trade-ins, and zero-percent financing, that enhance access to premium tools and accessories for contractors.

Major ongoing projects, such as the Los Filos Expansion (2021–2026), Abujar Gold Project (2021–2024), KoBold Metals Project (2022–2024), and the Khoemacau Copper Project (2021–2024), highlight the South’s strategic role in sustaining industrial activity. These developments demand durable, high-performance accessories tailored for mining and heavy-duty construction, reinforcing the region’s position as a critical driver of market growth.

 

Looking for More Information? Click: https://www.arizton.com/market-reports/us-power-tool-accessories-market

 

Key Company Profiles

  • Stanley Black & Decker
  • Robert Bosch
  • Milwaukee Tool
  • Makita U.S.A., Inc
  • AIMCO
  • Oregon Tool, Inc.
  • Emerson Electric Co
  • Ridgid
  • SKIL
  • Craftsman
  • Snap-on Incorporated

 

Other Prominent Company Profiles

  • Diablo Tools
  • Ryobi
  • Dewalt
  • Dremel
  • Chicago Pneumatic
  • Matco Tools
  • Cornwell Quality Tools
  • Senco Brands, Inc
  • Paslode
  • Chervon Holdings Limited
  • FEIN Power Tools, Inc
  • FERM
  • Festool GmbH
  • Dynabrade Inc
  • Husqvarna Group
  • Atlas Copco
  • Ingersoll Rand
  • Metabo
  • Proxxon
  • Worx

 

Market Segmentation & Forecast

Operations Type

  • Cutting
  • Drilling
  • Fastening
  • Routing and Planning
  • Others

Accessory Type

  • Drill Bits
  • Circular Saw Blades
  • Batteries
  • Screwdriver Bits
  • Reciprocating Saw Blades
  • Jigsaw Blades
  • Band Saw Blades
  • Abrasive Wheels
  • Router Bits
  • Others

End Users

  • Industrial
  • Commercial
  • Residential

Industrial End Users

  • Energy
  • Construction
  • Aerospace
  • Automotive
  • Electronics
  • Shipbuilding
  • Others

Distribution Channel

  • Offline
  • Online

Geography

  • The U.S.
  • South
  • West
  • Midwest
  • Northeast

 

Other Related Reports that Might be of Your Business Requirement   

Cordless Power Tool Market Research Report 2025 – 2030

https://www.arizton.com/market-reports/cordless-power-tool-market

Garden Hand Tools Market – Global Outlook & Forecast 2025-2030

https://www.arizton.com/market-reports/garden-hand-tools-market

 

What Key Findings Will Our Research Analysis Reveal?   

  • How big is the U.S. power tool accessories market?
  • What is the growth rate of the U.S. power tool accessories market?
  • Which region dominates the U.S. power tool accessories market share?
  • What are the significant trends in the U.S. power tool accessories industry?
  • Who are the key players in the U.S. power tool accessories market?

 

Why Arizton?                                              

100% Customer Satisfaction                                              

24×7 availability – we are always there when you need us                                              

200+ Fortune 500 Companies trust Arizton’s report                                              

80% of our reports are exclusive and first in the industry                                              

100% more data and analysis                                              

1500+ reports published till date                            

                 

Post-Purchase Benefit                                          

  • 1hr of free analyst discussion                                          
  • 10% off on customization                       

                

About Us:                                                                                   

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1 3122332770
Country: United States
Website: https://www.arizton.com/market-reports/us-power-tool-accessories-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Bosch, DeWalt, and Hilti Fuel U.S. Power Tool Accessories Market Growth to $5 Billion by 2030 Through Strategic State-Level Initiatives – Arizton

From Rural Advocate to National Change-Maker: Sally Turner Steps Up for Eating Disorder Awareness After Persuasive Presentation Training

From Rural Advocate to National Change-Maker: Sally Turner Steps Up for Eating Disorder Awareness After Persuasive Presentation Training
“The masterclass gave me the confidence to share my story and approach sponsors, funders, and decision-makers with clarity and impact,” said Sally.

North Sydney, NSW – June 17, 2025 – In honour of World Eating Disorders Action Day (June 15), rural change-maker Sally Turner is making bold moves to tackle one of the most misunderstood mental health challenges affecting regional Australians.

After participating in Michelle Bowden’s Persuasive Presentation Skills Masterclass (a transformative initiative funded by AgriFutures Australia) Sally has skyrocketed her advocacy efforts and grown The Wattle Project, her grassroots organisation dedicated to improving awareness, education, and access to support for people living with eating disorders in rural and regional communities.

“The masterclass gave me the confidence to share my story and approach sponsors, funders, and decision-makers with clarity and impact,” said Sally. “I left knowing how to tailor my message to inspire action—and it’s working.”

Since completing the course, Sally has:

  • Formed a board and is now applying for Not-for-Profit status
  • Created educational workshops for high school students, parents, and carers
  • Developed a community workshop model now in pilot across regional centres
  • Planned a national sponsorship campaign to fund resource development and workshop delivery
  • Launched the foundations of a Rural Ambassador Network—local voices championing The Wattle Project’s message across the country


These achievements come at a critical time:

  • Over 1.1 million Australians live with an eating disorder
  • Rural sufferers face disproportionate barriers, with treatment often costing $975 per person in travel
  • Stigma, service scarcity, and a lack of trained professionals continue to block support for regional families

Sally’s goal? To see every GP and nurse in rural Australia trained in eating disorder awareness, and every young person in the country’s heartland given the tools to seek help early.

Her persuasive skills are already opening global doors. Sally has just been announced as an Australian delegate to the World Food Forum in Rome this October through Global Voices, where she’ll present policy solutions on sustainable farming. She’s also been shortlisted for a Nuffield Scholarship—a prestigious program developing future leaders in agriculture.

“Sally Turner is proof that when you equip the right people with the right skills, extraordinary things happen,” said presentation expert and CSP Michelle Bowden. “It’s been an honour to watch her transform her message into a movement.”

Media Contact
Company Name: Michelle Bowden Enterprises
Contact Person: Michelle Bowden
Email: Send Email
Phone: +61 412 391 170
Address:PO Box 1247
City: North Sydney
State: NSW
Country: Australia
Website: https://michellebowden.com.au/

Patti Lynne’s “Pneuma: A True Fable” Weaves Holocaust Memory with Personal Healing in Powerful Debut

A Luminous New Novel Delivers a Timeless Story of Love, Loss, and Connection, Bridging Childhood Trauma and Miracles Found in the Quiet Corners of History and Spirit.

In her powerful debut, Pneuma: A True Fable, author Patti Lynne shares a story that reaches across time, loss, and healing. It’s a deeply personal and unforgettable journey, one that gently moves between the living and the spirit world, the pain we carry, and the hope that finds us.

Told through the lives of two young girls, one from the time of the Holocaust, the other growing up decades later, Pneuma is a moving tribute to the strength of the human spirit and the quiet ways we are all connected. It’s a reminder that some stories stay with us for a reason, and that healing can come when we least expect it even through those we’ve never met.

One Spirit Child. Two Lives Forever Changed

Gerti, a four-year-old spirit child, is born into a Hungarian Jewish family during the darkest days of the Holocaust. She is no ordinary girl. Her mission is divine: to guide the lost souls of 200,000 children who perished in Auschwitz-Birkenau to the peace they were denied in life.

Decades later, Patti, a young American born under the shadow of silence and abuse, carries her own invisible wounds. Marked at birth by a striking port wine stain and later burdened by trauma and illness, Patti’s journey unfolds in parallel to Gerti’s. As her body heals through a life-saving transplant, her spirit awakens to a haunting call that pulls her across oceans and memory to the birch grove in Auschwitz, where Gerti waits.

Where Memory Meets Mystery And History Finds a Voice

Part history, part spirit journey, Pneuma is rooted in real events and shaped by deep emotional truth. It walks gently through some of the darkest chapters in human history where families were torn apart and childhoods ended far too soon and into the quiet struggles hidden inside a home. And yet, within all that sorrow, it finds something extraordinary: the power to heal, sometimes in the most unexpected places.

Patti Lynne’s own story is woven through every page with honesty and heart. Her journey is raw and brave, filled with moments that are hard to face but always guided by a quiet hope that healing is possible, even in the places we thought were beyond repair

Some Stories Don’t Just Touch You, They Stay With You

What makes Pneuma: A True Fable truly special is how deeply it feels. Every word carries the weight of real emotion. Every moment is touched by something quiet and true. Patti Lynne doesn’t just tell a story. She shares something lived and deeply felt, drawn from memory, instinct, and a kind of knowing that speaks straight to the heart.

From the haunting silence of Birkenau to a childhood bedroom in 1960s Turkey, from whispered prayers to a life-changing moment in a distant grove, Pneuma gently leads us through the tender spaces where pain meets grace and where something sacred begins to take root.

What Early Readers Are Saying

“Pneuma: A True Fable is the kind of book that stays with you. It’s gentle, powerful, and full of feeling. Even after you’ve finished reading, it keeps echoing in your heart.” — Trish Kinney, writer and editor

“This story is brave and deeply personal. There is no way to avoid the bitterly honest truth; at the same time, the darkest places can still emit that light.” — Michael Reinhold, literary reviewer

Meet Author Patti Lynne

Patti Lynne has lived a life shaped by resilience, reflection, and a deep curiosity about what lies beyond what we can see. She’s a storyteller who writes from the heart, drawing on her own journey through pain, healing, and unexpected grace. Pneuma is her first book, one born from real experiences and a quiet calling to share them. Patti lives and writes in the American Southwest, where the land itself seems to hold space for the stories she tells.

Availability

Pneuma is available in paperback and eBook formats through Amazon and other major booksellers.

Why This Story Matters Now

Pneuma: A True Fable is more than a book – it is a silent gift. For someone who struggled with being invisible and lonely, and having no clear path ahead, these pages speak to you with quiet sympathy. It’s not claiming to have all the answers but gently reminds us that healing can find the way even in the hardest places.

Open the book. Walk into the grove. Let the story meet you where you are.

Contact Details

Contact with our team for interviews, review copies, or speaking engagements.

Media Contact
Company Name: The Empire Publishers (USA)
Contact Person: Patti Lynne
Email: Send Email
State: Arizona
Country: United States
Website: https://www.theempirepublishers.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Patti Lynne’s “Pneuma: A True Fable” Weaves Holocaust Memory with Personal Healing in Powerful Debut

IBN Technologies’ Accounting and Bookkeeping Services Empower New Jersey Businesses to Achieve Financial Clarity

“Accounting and Bookkeeping Services [USA]”
Businesses across New Jersey are increasingly adopting accounting and bookkeeping services to streamline operations, reduce overhead, and maintain compliance. As financial demands rise, companies seek expert-led solutions that deliver cost-effective, secure, and scalable results. IBN Technologies emerges as a trusted provider, offering customized support that improves accuracy and enables strategic financial growth.

Miami, Florida, 17 June 2025 – As financial pressures mount across industries, businesses in New Jersey are turning to accounting and bookkeeping services improve decision-making, boost operational efficiency, and ensure compliance. Small and mid-sized businesses, whether in the retail, construction, professional services, or healthcare sectors, are looking for trustworthy financial solutions that offer insights that can be used beyond simple reporting. The demand points to a significant departure from conventional internal teams in favor of adaptable, expert-driven substitutes that foster long-term expansion.

To choose the optimum structure for their financial management, businesses are also analyzing the difference between bookkeeping and accounting considering increased regulatory scrutiny and internal expenses. Without the expense of full-time personnel, outsourced models provide access to seasoned experts, efficient workflows, and strong financial visibility. In this context, companies such as IBN Technologies are establishing new benchmarks by offering customized, safe, and economical services that are particularly designed to meet the changing demands of the business community in New Jersey.

Simplify Finance and Stay in Control

Start Your Free Trial Today: https://www.ibntech.com/free-trial/

The Rising Complexity of Internal Financial Operations

Basic tracking is frequently the first step in internal financial management, but as firms grow, it soon becomes unsustainable. Growing issues with staffing and compliance confront financial executives and entrepreneurs. Outdated tools and limited capacity can limit performance and raise risk, particularly when important team members go or when company volumes change.

• Delays in monthly closing, affecting timely reports and planning

• Overdependence on specific staff, creating knowledge gaps and bottlenecks

• Difficulty implementing advanced bookkeeping software for small businesses

• Higher costs due to hiring, training, and employee turnover

• Fragmented data sources, reducing accuracy and transparency

To combat these issues, many organizations are exploring outsourced accounting and bookkeeping solutions. IBN Technologies stands out by offering scalable systems designed to eliminate inefficiencies and reduce exposure to risk. This empowers internal teams to focus on revenue-driving initiatives while ensuring their financial records are in expert hands.

Rising Demand for End-to-End Financial Services

A growing number of small company owners in New Jersey are moving toward complete models as they realize the limitations of partial financial support. These comprehensive services provide strategic clarity without putting a burden on internal resources by managing everything from year-end tax support to daily transaction tracking.

✅ Full-cycle accountants bookkeeping services to ensure financial consistency

 

✅ Intelligent reporting that supports accurate forecasting and budgeting

 

✅ Tax preparation aligned with federal and state compliance standards

 

✅ Receivables and payables managed for improved working capital

 

✅ Financial advisory supported by cloud-based tools for smarter decisions

By leveraging systems developed around specific industries, IBN Technologies provides accounting and bookkeeping services that are both efficient and precise. Their flexibility allows for seamless adjustments as businesses grow or pivot, helping maintain compliance and profitability in a constantly changing economic environment.

Outsourcing Drives Real Results

Companies across the state are discovering that partnering with seasoned providers yields not just savings, but better outcomes across the board. IBN Technologies, for example, has built its reputation on measurable client success.

• Serving over 1,500 clients globally, with a 95% client retention rate

• Delivering up to 50% cost savings over in-house options

• Achieving 99% accuracy across all financial reporting metrics

• Secure data handling through encrypted, remote infrastructure

For businesses evaluating company bookkeeping solutions, these performance indicators provide the assurance needed to transition away from traditional methods. The shift is not merely transactional; it is strategic—offering real-time visibility, improved accountability, and peace of mind.

Explore Transparent Pricing Today

See Plan Options: https://www.ibntech.com/pricing/

Transforming Financial Strategy Through Trusted Partnerships

The demand for flexible, responsive, and expert-led financial monitoring keeps growing as businesses deal with ever-increasing complexity. As a result, virtual bookkeeping has emerged as a key enabler—offering real-time access, operational agility, and seamless financial oversight. Today, accounting and bookkeeping services are essential to the implementation of strategic plans rather than being viewed as supporting functions. Companies are switching from internal, static systems to dynamic partnerships that offer cost control, speed, and structure.

IBN Technologies, which combines industry-specific expertise with state-of-the-art tools and individualized assistance, has become a leading solution provider in New Jersey. They are a great option for companies looking for financial stability in unpredictable times because of their emphasis on providing measurable advantages, whether they be cost reductions, compliance assurance, or strategic clarity.

Related Services:           

Outsourced Finance and Accounting: https://www.ibntech.com/finance-and-accounting-services/           

 About IBN Technologies                

IBN Technologies LLC, an outsourcing specialist with 25 years of experience, serves clients across the United States, United Kingdom, Middle East, and India. Renowned for its expertise in RPA, Intelligent process automation includes AP Automation services like P2P, Q2C, and Record-to-Report. IBN Technologies provides solutions compliant with ISO 9001:2015, 27001:2022, CMMI-5, and GDPR standards. The company has established itself as a leading provider of IT, KPO, and BPO outsourcing services in finance and accounting, including CPAs, hedge funds, alternative investments, banking, travel, human resources, and retail industries. It offers customized solutions that drive efficiency and growth. 

Media Contact
Company Name: IBN Technologies LLC
Contact Person: Pradip
Email: Send Email
Phone: +1 844-644-8440
Address:66, West Flagler Street Suite 900 Miami, FL, USA 33130
City: Miami
State: Florida
Country: United States
Website: https://www.ibntech.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: IBN Technologies’ Accounting and Bookkeeping Services Empower New Jersey Businesses to Achieve Financial Clarity

TEÓNA Releases Empowering New Single “What I Want” – A Bold Anthem for Every Woman Who Once Had a Love So Bad It Felt Good

Rising genre-bending artist TEÓNA has released her bold new single, “What I Want”—an empowering anthem celebrating feminine freedom, self-worth, and unapologetic desire. With a sound that fuses R&B, soul, and pop, the track showcases Teóna’s poetic roots and magnetic vocal presence. Upcoming tour stops include Minneapolis, Havana, New Orleans, Washington D.C., and New York. The single is now streaming on all major platforms.

New York, NY – June 17, 2025 – Rising artist TEÓNA has officially released her latest single, “What I Want”, now available on all major streaming platforms. The track is a sultry, empowering anthem for women who are owning their desires, their space, and their standards—unapologetically.

Blending elements of R&B, soul, and pop with a fresh, confident delivery, “What I Want” captures the essence of feminine power and the freedom that comes with putting yourself first. From the opening beat to the final hook, Teóna’s vocals ride effortlessly over an upbeat, free-spirited production, drawing comparisons to classic sirens like Donna Summer and modern muses like Jhené Aiko.

“Life is for living,” TEÓNA says. “It’s about being honest about what you want—and being unapologetic about it.”

Known for her rich storytelling and magnetic stage presence, TEÓNA fuses her roots in poetry, performance, and disco music to create a unique sound that speaks to women who are choosing themselves in every way—from the boardroom to the bedroom.

With tour dates soon to be announced in Minneapolis, Havana, New Orleans, Washington D.C., and New York, “What I Want” sets the stage for a series of electrifying live performances that promise to leave listeners moved, empowered, and wanting more.

Stream “What I Want” today on Spotify, Apple Music, or your favorite platform, and follow @muse.teona on Instagram for exclusive behind-the-scenes content and upcoming show announcements.

About TEÓNA

TEÓNA is a genre-bending artist, entrepreneur, and storyteller who creates music for the bold, the soft, and the sacred. With roots in the American South and stories that span the globe, her artistry is rooted in freedom, sensuality, and truth.

If you’d like a clean, high-quality file of “What I Want” ready for radio rotation or your DJ set, please don’t hesitate to reach out. TEÓNA is also available for interviews, drops, guest features, and media appearances.

PRESS INQUIRIES & RADIO STREAMING:

Email: music@iamteona.com

Instagram: @muse.teona

Website: iamteona.com

Media Contact
Company Name: Brand Like A Celebrity®?
Contact Person: Tephanie Delaney
Email: Send Email
Country: United States
Website: iamteona.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: TEÓNA Releases Empowering New Single “What I Want” – A Bold Anthem for Every Woman Who Once Had a Love So Bad It Felt Good

Gaby Guha Officially Nominated as Miss Universe Bulgaria 2025

Gaby Guha is representing Bulgaria in Miss Universe 2025, continuing her career in fashion, business, and social advocacy.

Gaby Guha, an international fashion model and entrepreneur, has officially been nominated as Miss Universe Bulgaria 2025. The announcement confirms her participation in the upcoming Miss Universe pageant, representing Bulgaria on a global stage. Known for her modeling work and involvement in philanthropic causes, Guha adds another chapter to her career with this official title.

Originally crowned Miss Europe in 2020, Gaby Guha has steadily built a profile that spans fashion, media, and business. She has worked with several luxury fashion brands, including Chaumet, Elie Saab, Jean Louis David, GAP, Bossini, Triumph Lingerie, and Robert Abi Nader. Her presence has extended to magazine covers such as Prestige, ICON, Gmaro, and L’Officiel. Television appearances on channels including Fashion TV, Canal+, M6, and MTV have helped increase her visibility across Europe and the Middle East.

Her official nomination as Miss Universe Bulgaria follows months of anticipation after she announced her intent to compete in Miss Universe 2025 earlier this year. With this step, Guha now prepares to represent Bulgaria on one of the most recognized global platforms in the world of pageantry.

Beyond her modeling career, Guha is active in business and social initiatives. She is the founder of Gaby Beauty, a cosmetics and skincare brand, and G Global, a real estate investment company. Both ventures reflect her interest in business development and her aim to diversify her professional commitments beyond fashion.

Gaby Guha’s nomination also brings attention to her ongoing work in advocacy. She has supported initiatives focused on education, women’s safety, and health. Her association with The Pink Ribbon Foundation in London highlights her continued interest in causes related to breast cancer awareness and women’s well-being.

Speaking previously about her participation in Miss Universe, Guha emphasized that her involvement is not only about competition but also about representation and influence. She views the platform as a way to highlight issues that matter to her and to support others who are working toward personal and social growth.

With the official confirmation of her title as Miss Universe Bulgaria 2025, Guha is expected to share her preparation journey and upcoming activities with her followers on social media. Her Instagram account, already a source of updates on her modeling and professional life, will continue to offer a closer look into the months ahead as she prepares for the pageant.

Gaby Guha’s selection marks a new development in her career, combining public recognition with an opportunity to represent Bulgaria in front of an international audience. Her focus remains on maintaining a meaningful presence that extends beyond appearances and into areas of work that reflect her values and long-term interests.

For updates, insights, and behind-the-scenes content, Gaby Guha can be followed on Instagram at www.instagram.com/gabyguha

Media Contact
Company Name: Gaby Guha Communication
Contact Person: Media Relations Team
Email: Send Email
Country: United Arab Emirates
Website: www.instagram.com/gabyguha

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Gaby Guha Officially Nominated as Miss Universe Bulgaria 2025

Buck Stove & Spa Unveils Brand New Website, Bringing Premier Hot Tubs, Stoves, and Fireplaces to Visalia Online

“Buck Stove & Spa Storefront”
The new website serves as a comprehensive showcase for Buck Stove & Spa’s diverse inventory, which includes a wide selection of luxurious hot tubs perfect for relaxation and hydrotherapy, as well as a variety of wood, pellet, and gas stoves engineered for optimal heating efficiency. Visitors can also browse an impressive array of fireplaces, ranging from traditional masonry to contemporary electric models, all designed to add warmth, ambiance, and value to any home.

VISALIA, CA – June 17, 2025 – Buck Stove & Spa, Visalia’s trusted destination for high-quality hot tubs, efficient stoves, and elegant fireplaces, today announced the official launch of its brand new website: www.buckstoveandspas.com. This modern digital platform is designed to enhance the customer experience, making it easier than ever for local residents to explore the company’s extensive product offerings from the comfort of their homes.

The new website serves as a comprehensive showcase for Buck Stove & Spa’s diverse inventory, which includes a wide selection of luxurious hot tubs perfect for relaxation and hydrotherapy, as well as a variety of wood, pellet, and gas stoves engineered for optimal heating efficiency. Visitors can also browse an impressive array of fireplaces, ranging from traditional masonry to contemporary electric models, all designed to add warmth, ambiance, and value to any home.

“We are incredibly excited to launch our new website,” said Bob Haun, Owner of Buck Stove & Spa. “For years, we’ve been dedicated to providing Visalia and the surrounding communities with top-tier products and exceptional service in person. This new online presence allows us to extend that commitment by offering a convenient, accessible way for customers to discover our full range of hot tubs, stoves, and fireplaces before they even step into our showroom. It’s a significant step forward in serving our community better.”

Key features of the new website include:

  • Intuitive Navigation: A user-friendly interface allows for seamless browsing across product categories.
  • Detailed Product Pages: Each product features high-resolution images, comprehensive descriptions, and key specifications.
  • Customer Resources: Information on maintenance, installation, and financing options.
  • Contact & Location Information: Easy access to showroom hours, address, and contact details for personalized assistance.

The launch of the website reflects Buck Stove & Spa’s ongoing commitment to innovation and customer satisfaction, ensuring that the warmth and comfort they provide extends beyond their physical storefront directly to their clients’ fingertips.

About Buck Stove & Spa:

Buck Stove & Spa has proudly served the Visalia community for over 10 years, specializing in the sale, installation, and service of premium hot tubs, wood stoves, pellet stoves, gas stoves, and fireplaces. Committed to quality and customer satisfaction, Buck Stove & Spa helps homeowners create comfortable, efficient, and beautiful living spaces.

Media Contact
Company Name: Buck Stove & Spa
Contact Person: Bob Haun, Owner
Email: Send Email
Phone: (559) 627-2205
Address:1830 W Caldwell Ave
City: Visalia
State: CA
Country: United States
Website: www.buckstoveandspas.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Buck Stove & Spa Unveils Brand New Website, Bringing Premier Hot Tubs, Stoves, and Fireplaces to Visalia Online

Chronic Lymphocytic Leukemia Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s, “Chronic Lymphocytic Leukemia Pipeline Insight 2025” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Chronic Lymphocytic Leukemia (CLL) pipeline landscape. It covers the Chronic Lymphocytic Leukemia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Stay ahead with the latest insights! Download DelveInsight’s comprehensive Chronic Lymphocytic Leukemia Pipeline Report to explore emerging therapies, key players, and future treatment landscapes @ Chronic Lymphocytic Leukemia Pipeline Outlook Report

Key Takeaways from the Chronic Lymphocytic Leukemia Pipeline Report

  • In June 2025, BeiGene announced a study is to support the registration plan of sonrotoclax plus zanubrutinib treatment in participants with previously untreated CLL. This study is designed to assess the contribution of sonrotoclax to the efficacy outcome of the combination of zanubrutinib and sonrotoclax.
  • In June 2025, German CLL Study Group conducted a phase 3 study is designed to demonstrate that treatment with a triple combination of acalabrutinib, obinutuzumab and venetoclax (GAVe) prolong the progression-free survival (PFS) as compared to treatment with the combination of obinutuzumab and venetoclax (GVe) in pa-tients with high risk CLL (defined as having at least one of the follow-ing risk factors: 17p-deletion, TP53-mutation or complex karyotype).
  • In June 2025, Acerta Pharma BV organized a Phase III Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia.
  • The leading Chronic Lymphocytic Leukemia Companies such as Loxo Oncology, Oncternal Therapeutics, MingSight Pharmaceuticals, Nurix Therapeutics, Starton Therapeutics, TG Therapeutics, Bristol Myers Squibb, Novartis, Aprea Therapeutics, AstraZeneca, Genor Biopharma, Incyte Corporation, MorphoSys, Astex Therapeutics, Lava Therapeutics, Celgene Corporation, and others.
  • Promising Chronic Lymphocytic Leukemia Therapies such as Obinutuzumab, Rituximab, Chlorambucil, Acalabrutinib, and others.

Discover how the Chronic Lymphocytic Leukemia treatment paradigm is evolving. Access DelveInsight’s in-depth Chronic Lymphocytic Leukemia Pipeline Analysis for a closer look at promising breakthroughs @ Chronic Lymphocytic Leukemia Clinical Trials and Studies

Chronic Lymphocytic Leukemia Emerging Drugs Profile

  • Pirtobrutinib: Loxo Oncology

Pirtobrutinib is an investigational, oral, highly-selective, non-covalent Bruton’s tyrosine kinase (BTK) inhibitor. BTK plays a key role in the B-cell antigen receptor, signaling pathway, which is required for the development, activation and survival of normal white blood cells, known as B-cells, and malignant B-cells. Pirtobrutinib was designed to reversibly bind BTK, deliver consistently high target coverage regardless of BTK turnover rate, preserve activity in the presence of the C481 acquired resistance mutations, and avoid off-target kinases that have complicated the development of both covalent and investigational non-covalent BTK inhibitors. The drug is currently being evaluated in Phase III stage of development for the treatment of chronic lymphocytic leukemia.

  • Cirmtuzumab: Oncternal Therapeutics

Cirmtuzumab is a first-in-class humanized monoclonal antibody that binds with high affinity to a biologically important epitope on ROR1 (Receptor-tyrosine kinase-like Orphan Receptor 1). ROR1 is a type 1 transmembrane protein, essential for fetal development that is expressed on the plasma membrane with an extracellular domain that is essential for ligand binding and signal transduction. Cirmtuzumab binds to many different types of cancer cells but does not recognize most normal adult tissues. Cirmtuzumab was developed at the University of California in San Diego based on the pioneering scientific research of Thomas Kipps, MD, Ph.D., and his colleagues at the Moores Cancer Center. Oncternal holds an exclusive worldwide license to develop and commercialize antibodies recognizing ROR1. The development of cirmtuzumab has been supported by the California Institute for Regenerative Medicine (CIRM), in recognition of the role of ROR1 in conferring stem cell-like properties to the cancer cells that express it. A Phase II clinical trial is evaluating Cirmtuzumab to treat CLL.

  • MS-553: MingSight Pharmaceuticals

MS-553 is a potent, highly selective, oral, non-covalent inhibitor of PKCβ, a signaling molecule immediately downstream of BTK and PLCγ2 in the B-cell receptor (BCR) pathway. As PKCβ is downstream of both BTK and PLCγ2, it has the potential to treat acquired BTK resistance mutations in either protein, a feature absent from many second-generation BTK inhibitors. In the preliminary results, MS-553 was generally well tolerated, with initial anti-tumor activity seen in the heavily pretreated population. Potent to full inhibition of PKCβ signaling over 24 hours of exposure has been demonstrated. Additional dosing of patients will be completed to further assess MS-553 efficacy in patients with acquired resistance mutations in BTK and PLCG2. Currently, the drug is being evaluated in the Phase I/II stage of its development for the treatment of CLL.

  • NX-2127: Nurix Therapeutics

NX-2127 is an oral small molecule that combines the activity of a targeted BTK degrader with the cereblon immunomodulatory activity of an IKZF degrader. Cereblon immunomodulatory drugs that induce degradation are IKZF1 and IKZF3. Preclinical data support the activity of NX-2127 in tumor models harboring either wild-type BTK or BTK with mutations conferring clinical resistance to FDA-approved agents. Studies in non-human primates confirm potent BTK degradation with once-daily oral dosing. NX-2127 is being tested in an ongoing Phase I trial for patients with chronic lymphocytic leukemia who have failed prior treatments.

  • NX-5948: Nurix Therapeutics

NX-5948 is an oral small molecule degrader of BTK. Preclinical data support the activity of NX-5948 in tumor models harboring either wild-type BTK or BTK with mutations conferring clinical resistance to leading FDA approved agents. NX-5948 lacks cereblon immunomodulatory activity and has demonstrated the ability to cross the blood-brain barrier in animal models. NX-5948 has also demonstrated activity in animal models of autoimmune disease. The drug is currently being evaluated in the Phase I stage of development for the treatment of chronic lymphocytic leukemia.

The Chronic Lymphocytic Leukemia Pipeline Report Provides Insights into

  • The report provides detailed insights about companies that are developing therapies for the treatment of Chronic Lymphocytic Leukemia with aggregate therapies developed by each company for the same.
  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Chronic Lymphocytic Leukemia Treatment.
  • Chronic Lymphocytic Leukemia Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • Chronic Lymphocytic Leukemia Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Chronic Lymphocytic Leukemia market

Explore groundbreaking therapies and clinical trials in the Chronic Lymphocytic Leukemia Pipeline. Access DelveInsight’s detailed report now! @ New Chronic Lymphocytic Leukemia Drugs

Chronic Lymphocytic Leukemia Companies

Loxo Oncology, Oncternal Therapeutics, MingSight Pharmaceuticals, Nurix Therapeutics, Starton Therapeutics, TG Therapeutics, Bristol Myers Squibb, Novartis, Aprea Therapeutics, AstraZeneca, Genor Biopharma, Incyte Corporation, MorphoSys, Astex Therapeutics, Lava Therapeutics, Celgene Corporation, and others.

Chronic lymphocytic leukemia pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

  • Intravenous
  • Subcutaneous
  • Oral
  • Intramuscular

Chronic Lymphocytic Leukemia Products have been categorized under various Molecule types such as

  • Monoclonal antibody
  • Small molecule
  • Peptide

Download DelveInsight’s latest report to gain strategic insights into upcoming therapies and key developments @ Chronic Lymphocytic Leukemia Market Drivers and Barriers, and Future Perspectives

Scope of the Chronic Lymphocytic Leukemia Pipeline Report

  • Coverage- Global
  • Chronic Lymphocytic Leukemia Companies- Loxo Oncology, Oncternal Therapeutics, MingSight Pharmaceuticals, Nurix Therapeutics, Starton Therapeutics, TG Therapeutics, Bristol Myers Squibb, Novartis, Aprea Therapeutics, AstraZeneca, Genor Biopharma, Incyte Corporation, MorphoSys, Astex Therapeutics, Lava Therapeutics, Celgene Corporation, and others.
  • Chronic Lymphocytic Leukemia Therapies- Obinutuzumab, Rituximab, Chlorambucil, Acalabrutinib, and others.
  • Chronic Lymphocytic Leukemia Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Chronic Lymphocytic Leukemia Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

Which companies are leading the race in Chronic Lymphocytic Leukemia drug development? Find out in DelveInsight’s exclusive Chronic Lymphocytic Leukemia Pipeline Report—access it now! @ Chronic Lymphocytic Leukemia Emerging Drugs and Major Companies

Table of Content

  1. Introduction
  2. Executive Summary
  3. Chronic lymphocytic leukemia: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Chronic lymphocytic leukemia– DelveInsight’s Analytical Perspective
  7. Late Stage Products (Phase III)
  8. Pirtobrutinib: Loxo Oncology
  9. Drug profiles in the detailed report…..
  10. Mid Stage Products (Phase II)
  11. Cirmtuzumab: Oncternal Therapeutics
  12. Drug profiles in the detailed report…..
  13. Early Stage Products (Phase I)
  14. NX-2127: Nurix Therapeutics
  15. Drug profiles in the detailed report…..
  16. Preclinical and Discovery Stage Products
  17. Drug name: Company name
  18. Drug profiles in the detailed report…..
  19. Inactive Products
  20. Chronic lymphocytic leukemia Key Companies
  21. Chronic lymphocytic leukemia Key Products
  22. Chronic lymphocytic leukemia- Unmet Needs
  23. Chronic lymphocytic leukemia- Market Drivers and Barriers
  24. Chronic lymphocytic leukemia- Future Perspectives and Conclusion
  25. Chronic lymphocytic leukemia Analyst Views
  26. Chronic lymphocytic leukemia Key Companies
  27. Appendix

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/chronic-lymphocytic-leukemia-cll-pipeline-insight

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Chronic Lymphocytic Leukemia Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

Complement 3 Glomerulopathy Pipeline Appears Robust With 3+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s, “Complement 3 Glomerulopathy Pipeline Insight 2025” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Complement 3 Glomerulopathy pipeline landscape. It covers the Complement 3 Glomerulopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Complement 3 Glomerulopathy pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Stay ahead with the latest insights! Download DelveInsight’s comprehensive Complement 3 Glomerulopathy Pipeline Report to explore emerging therapies, key players, and future treatment landscapes @ Complement 3 Glomerulopathy Pipeline Outlook Report

Key Takeaways from the Complement 3 Glomerulopathy Pipeline Report

  • In April 2025, Novartis Pharmaceuticals announced a study Baseline/Day 1 visit is equivalent to the End of Treatment visit of the parent study. The study will begin on Day 1 followed by on-site visits every 4 months during the study treatment period. A Safety Follow Up tele-visit must be conducted 7 days after last study treatment to collect information on Adverse Events.
  • DelveInsight’s Complement 3 Glomerulopathy pipeline report depicts a robust space with 3+ active players working to develop 3+ pipeline therapies for Complement 3 Glomerulopathy treatment.
  • The leading Complement 3 Glomerulopathy Companies such as ChemoCentryx, Novartis Pharmaceuticals, Omeros Corporation, Apellis Pharmaceuticals and others.
  • Promising Complement 3 Glomerulopathy Pipeline Therapies such as Iptcaopan 200 mg, Pegcetacoplan, and others.

Discover how the Complement 3 Glomerulopathy treatment paradigm is evolving. Access DelveInsight’s in-depth Complement 3 Glomerulopathy Pipeline Analysis for a closer look at promising breakthroughs @ Complement 3 Glomerulopathy Clinical Trials and Studies

Complement 3 Glomerulopathy Emerging Drugs Profile

  • Avacopan: Novartis Pharmaceuticals

Avacopan is an orally-administered drug candidate that inhibits the complement C5a receptor, or C5aR, and is being developed for inflammatory and autoimmune diseases. Avacopan blocks the activity of complement C5a, a component of the complement system and the natural ligand for C5aR. It is in phase II stage of development to treat C3 Glomerulopathy

  • LNP 023: Novartis Pharmaceuticals

Iptacopan is an investigational, first-in-class, orally administered factor B inhibitor of the alternative complement pathway, targeting one of the key drivers of these diseases9-11. It has the potential to become the first targeted therapy to delay progression to dialysis in C3G. It is in phase II stage of development to treat C3 Glomerulopathy

The Complement 3 Glomerulopathy Pipeline Report Provides Insights into

  • The report provides detailed insights about companies that are developing therapies for the treatment of Complement 3 Glomerulopathy with aggregate therapies developed by each company for the same.
  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Complement 3 Glomerulopathy Treatment.
  • Complement 3 Glomerulopathy Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • Complement 3 Glomerulopathy Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Complement 3 Glomerulopathy market

Explore groundbreaking therapies and clinical trials in the Complement 3 Glomerulopathy Pipeline. Access DelveInsight’s detailed report now! @ New Complement 3 Glomerulopathy Drugs

Complement 3 Glomerulopathy Companies

ChemoCentryx, Novartis Pharmaceuticals, Omeros Corporation, Apellis Pharmaceuticals and others.

Complement 3 Glomerulopathy pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

  • Oral
  • Parenteral
  • Intravenous
  • Subcutaneous
  • Topical.
  • Molecule Type

Complement 3 Glomerulopathy Products have been categorized under various Molecule types such as

  • Monoclonal Antibody
  • Peptides
  • Polymer
  • Small molecule
  • Gene therapy
  • Product Type

Download DelveInsight’s latest report to gain strategic insights into upcoming therapies and key developments @ Complement 3 Glomerulopathy Market Drivers and Barriers, and Future Perspectives

Scope of the Complement 3 Glomerulopathy Pipeline Report

  • Coverage- Global
  • Complement 3 Glomerulopathy Companies- ChemoCentryx, Novartis Pharmaceuticals, Omeros Corporation, Apellis Pharmaceuticals and others.
  • Complement 3 Glomerulopathy Pipeline Therapies- Iptcaopan 200 mg, Pegcetacoplan, and others.
  • Complement 3 Glomerulopathy Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Complement 3 Glomerulopathy Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

Which companies are leading the race in Complement 3 Glomerulopathy drug development? Find out in DelveInsight’s exclusive Complement 3 Glomerulopathy Pipeline Report—access it now! @ Complement 3 Glomerulopathy Emerging Drugs and Major Companies

Table of Content

  1. Introduction
  2. Executive Summary
  3. Complement 3 Glomerulopathy: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Late Stage Products (Phase III)
  7. Drug name: Company name
  8. Drug profiles in the detailed report…..
  9. Mid Stage Products (Phase II)
  10. Iptacopan: Novartis
  11. Drug profiles in the detailed report…..
  12. Early Stage Products (Phase I)
  13. Drug name: Company name
  14. Drug profiles in the detailed report…..
  15. Preclinical and Discovery Stage Products
  16. Drug name: Company name
  17. Drug profiles in the detailed report…..
  18. Inactive Products
  19. Complement 3 Glomerulopathy Key Companies
  20. Complement 3 Glomerulopathy Key Products
  21. Complement 3 Glomerulopathy- Unmet Needs
  22. Complement 3 Glomerulopathy- Market Drivers and Barriers
  23. Complement 3 Glomerulopathy- Future Perspectives and Conclusion
  24. Complement 3 Glomerulopathy Analyst Views
  25. Complement 3 Glomerulopathy Key Companies
  26. Appendix

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/complement-3-glomerulopathy-pipeline-insight

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Complement 3 Glomerulopathy Pipeline Appears Robust With 3+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight